Themis Medicare Limited (THEMISMED) - Total Liabilities
Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has total liabilities worth Rs2.02 Billion INR (≈ $21.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Themis Medicare Limited annual equity growth to track the company's year-over-year net asset growth rate.
Themis Medicare Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Themis Medicare Limited's total liabilities have evolved over time, based on quarterly financial data. See Themis Medicare Limited (THEMISMED) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Themis Medicare Limited Competitors by Total Liabilities
The table below lists competitors of Themis Medicare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GENOR BIOPHARMA DL-00002
F:67N0
|
Germany | €226.09 Million |
|
Seah Spe Steel
KO:019440
|
Korea | ₩331.57 Billion |
|
Shin Foong Specialty and Applied Materials Co
TW:6582
|
Taiwan | NT$201.69 Million |
|
Azevedo & Travassos S.A
SA:AZEV3
|
Brazil | R$1.06 Billion |
|
Tunghsu Azure Renewable Energy Co Ltd
SHE:000040
|
China | CN¥12.07 Billion |
|
Kangnam Jevisco Co Ltd
KO:000860
|
Korea | ₩290.94 Billion |
|
TTEC Holdings Inc
NASDAQ:TTEC
|
USA | $1.31 Billion |
|
Duro Felguera
MC:MDF
|
Spain | €467.48 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Themis Medicare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Themis Medicare Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Themis Medicare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Themis Medicare Limited (2006–2025)
The table below shows the annual total liabilities of Themis Medicare Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs1.85 Billion ≈ $20.05 Million |
-1.76% |
| 2024-03-31 | Rs1.89 Billion ≈ $20.41 Million |
+8.16% |
| 2023-03-31 | Rs1.75 Billion ≈ $18.87 Million |
+24.39% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
-8.09% |
| 2021-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-8.54% |
| 2020-03-31 | Rs1.67 Billion ≈ $18.05 Million |
+6.96% |
| 2019-03-31 | Rs1.56 Billion ≈ $16.87 Million |
+14.38% |
| 2018-03-31 | Rs1.36 Billion ≈ $14.75 Million |
-27.94% |
| 2017-03-31 | Rs1.89 Billion ≈ $20.47 Million |
-4.03% |
| 2016-03-31 | Rs1.97 Billion ≈ $21.33 Million |
-10.50% |
| 2015-03-31 | Rs2.20 Billion ≈ $23.84 Million |
-3.64% |
| 2014-03-31 | Rs2.29 Billion ≈ $24.74 Million |
+4.12% |
| 2013-03-31 | Rs2.20 Billion ≈ $23.76 Million |
-0.83% |
| 2012-03-31 | Rs2.22 Billion ≈ $23.96 Million |
+9.14% |
| 2011-03-31 | Rs2.03 Billion ≈ $21.95 Million |
+5.31% |
| 2010-03-31 | Rs1.93 Billion ≈ $20.84 Million |
-4.83% |
| 2009-03-31 | Rs2.03 Billion ≈ $21.90 Million |
+7.64% |
| 2008-03-31 | Rs1.88 Billion ≈ $20.35 Million |
+15.97% |
| 2007-03-31 | Rs1.62 Billion ≈ $17.54 Million |
+67.46% |
| 2006-03-31 | Rs968.77 Million ≈ $10.48 Million |
-- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more